Founded in 2015, Guangdong Taiyuan Technology Group focuses on peptide R&D, manufacturing, sales and related services with advanced and efficient synthesis, purification and scale-up capabilities.
Founded in 2015, Guangdong Taiyuan Technology Group focuses on peptide R&D, manufacturing, sales and related services, with advanced and efficient peptide synthesis, purification and scale-up capabilities. It is a National Specialized and Sophisticated Enterprise with a Guangdong postdoctoral workstation and a Shaoxing academician expert workstation. With a mission focused on human health and beauty, the company supplies peptide cosmetic ingredients and pharmaceutical peptide products to downstream customers.
After years of technical accumulation and process exploration, the company has built an industry-leading peptide drug synthesis and manufacturing platform with core scale-up technologies. Its process R&D and manufacturing capabilities support a rich product pipeline covering Leuprorelin, Semaglutide, Liraglutide, Linaclotide and other well-known products.
Since establishment, the company has provided peptide CDMO/CRO services to well-known innovative pharmaceutical companies including China Resources Double-Crane and Simcere, with peptide APIs and advanced intermediates exported to the USA, Russia, Pakistan, Korea and other regions.
The company pursues independent innovation, continues to develop peptide cosmetic ingredient projects, and actively cooperates with Proya, Bloomage Biotech, Marubi and other leading cosmetic companies, empowering peptide applications in cosmetic ingredients through scientific expertise and successful application experience.
According to Frost & Sullivan, the company was China's largest peptide cosmetic ingredient manufacturer by market share in 2021 and one of the few domestic companies capable of kilogram-scale Semaglutide API production.
Focused on peptide R&D and manufacturing, aiming to become an internationally recognized peptide brand.
Making peptides more accessible
Empowering people to be healthier and more beautiful
Guangdong Taiyuan Technology Group, technology-driven innovation
As a biotechnology company with leading peptide synthesis and modification technologies, Guangdong Taiyuan Technology Group has accumulated rich experience in peptide R&D, manufacturing processes and pharmaceutical applications. It has successfully synthesized and scaled up multiple peptide APIs including Leuprorelin, Liraglutide and Semaglutide.
The company is a leader in peptide cosmetic ingredients, with strong scale-up manufacturing capabilities and a diverse product portfolio covering signal peptides, neurotransmitter-inhibiting peptides, carrier peptides and specialty functional peptides.
In cosmetic ingredients, we provide full-chain services from early product development, R&D, experiments, powder production and solution preparation to stability testing and efficacy evaluation. In pharmaceuticals, our products and services cover the full peptide API R&D and manufacturing value chain.
With years of industry experience and deep peptide know-how, we can participate from early product design, tailor peptide ingredients for target positioning and use, and continuously upgrade solutions based on customer needs.
We have rich experience in peptide manufacturing processes and chemical properties, respond quickly to customer needs, and provide high-quality products with strong service capability and brand reputation.
Proprietary peptide synthesis and modification technologies underpin our scale-up manufacturing capabilities.
Contact our technical team through the buttons below to discuss project requirements.
